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CD8 is a surface glycoprotein expressed on most thymocytes and on a subset of
mature T cells. The reactivity ofmature CD8+ T cells is restricted by polymorphic
determinants on class I MHC molecules present on target cells; CD8 itself binds
to a monomorphic region ofclass I MHC proteins and increases the avidity ofthe
interactionbetweentheTcell and the antigen presenting cells (1, 2). Evidence from
experimentswithinbred transgenic micesupports thehypothesis thatthe CD8 mol-
ecule participates in the intrathymicselectionofclass I MHC-restricted T cells and
in the tolerization to selfantigens presented by class I proteins (3-7). Nocomparable
experimental evidence exists in any outbred species. In this article we describe an
immune deficient patient with selective depletion ofCD8+ cells. Analysis ofthis pa-
tient reveals the existence of CD8+ cells in the thymic cortex but selective deple-
tion of CD8+ cells in the thymic medulla and peripheral blood. Our results point
to a process in the human thymus that targets the CD8+ thymocyte.
Flow Cytometry
￿
Viable mononuclearcellsfromthymocyteswereisolatedusingFicoll/Hy-
paque. Isolated thymocytes were resuspended at 2 x 106 cells/ml in PBS containing fluo-
rescein-conjugated mAbsand incubated for30 min at 4°C. After two washes inPBS, labeled
cellswere analyzed by aCoulter EpicsV flowcytometer(CoulterElectronics, Hialeah, FL).
Immunohistological Analysis of Cryostat Sections.
￿
Thymic biopsies from the patient and from
anormal control, undergoing cardiac surgery, were snap frozen inliquid nitrogenandstored
at -70°Cuntiluse. 4-,um serial cryostat sections weremounted on glass slides and airdried.
Tissue sections were immunostainedwiththespecifiedmAbsusingathree-stagebiotin-avidin-
peroxidase staining.
Northern Blot Analysis.
￿
RNA was extracted from cells in guanidinum isothiocyanate ac-
cordingtothemethod ofChomezynski and Sacchi (8). Purified RNA(10 ug) waselectropho-
resed, subsequently transferredtonitrocellulose, blottedandhybridized with labeledprobes
as previously described (9).
Amplification ofCD8cDNA.
￿
A353-bp fragment ofCD8acDNAwasamplifiedasdescribed
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(10) from cDNA produced by reverse transcription (MMLV reverse transcriptase; Bethesda
Research Laboratories, Gaithersburg, MD) of RNA isolated from a thymus biopsy.
Amplification of 7UR V,B cDNAs.
￿
DNA fragments of various sizes were amplified as de-
scribed(8). RNA was transcribed from a primercommon to human TCR Sl and 02 constant
regions; the cDNA was amplified using the polymerase chain reaction (PCR) with a nested
second primer common to human TCR 01 and #2 constant regions together with a primer
corresponding to 1 of 20 VO families. Identity of the amplified DNA fragments was estab-
lished through hybridization to a third nested CS oligonucleotide.
Results and Discussion
A female infant with a selective deficiency of cell-mediated immunity presented
at 9 mo of age with Pneumocystis carinii pneumonia. Subsequently she developed chronic
diarrhea, and mini-reovirus was repeatedly isolated from her stool. She failed to
respond to the Candida skin test despite the persistence of oral thrush and ulcers
caused by this fungus. The apparent susceptibility to parasitic, viral, and fungal in-
fections coupled with the knowledge that the patient's older sibling was previously
diagnosed as severe combined immunodeficient (SLID) caused us to investigate further
her cellular immunity. At the age of 10 mo an allogeneic skin graft obtained from
an unrelated, healthy donor was applied and was not rejected by the patient. In con-
trast to the typical presentation ofSCID, her humoral responses were unexceptional:
Her Ig levels (IgM, IgG, and IgA) were within the normal range; she made anti-
body responses to tetanus toxoid, poliomyelitis, rubella, and measles viruses; and
she responded with primary and secondary antibody to the novel antigen OX174.
Whereas specific antibody responses require class II MHC antigen-restricted helper
T cells, allogeneic graft rejection and immunity to viral infection involve cytotoxic
class I MHC-restricted T cells. The clinical presentation ofthis patient is suggestive
of a deficiency of class I MHC-restricted T cells. To further examine this possibility
we carried out cellular and molecular analyses of the patient's lymphoid system.
We determined the expression of T cell-specific surface markers on the patient's
PBMC by flow cytometric analysis. The analysis revealed a lack of CD8' cells but
typical numbers of CD4+ cellsin the peripheral blood (Fig. 1). Levels ofexpression
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FIGURE 1.
￿
Analysil, by flow cytometry of T cell sur-
face antigens on peripheralblood cells from the unmune-
deficient patient and anormal control. Mononuclear cells
were separated from white blood cells on a Hypaque-
Ficoll gradient, stained withfluoresccin-conjugated mAbs
against CD8, CD4, and CD3 antigens or control anti-
bodies (MSIgGI), and analyzed using a Coulter Elec-
tronics Epics V flow cytometer.ROIFMAN ET AL.
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ofT cell surface markers CD2, CD3 (Fig. 1), and theT cell antigen receptor (data
not shown) were unremarkable. The number ofB lymphocytes in the peripheral
blood (asjudged by the number ofCD20' and sIg+ expressing cells) was also within
the normal range (data not shown) . Theclinical and immunological findings in this
patient are consistent with a selective deficiency of class I MHC antigen-restricted
T cell functions .
A structural mutation in theCD8 gene, resulting in a failure to express theCD8
protein, might explain the loss of peripheral CD8+ cells ; alack of positive selection
forCD8 + cells or active depletion ofCD8+ cells during intrathymic differentiation
could also account forthe selective depletion . To distinguish amongthese possibili-
ties, we analyzed thesurface expression ofCD8in a thymic biopsy that was obtained
at the ageof 10 mo. The morphology of the patient's thymus appeared normal, with
well-developed Hassall's corpuscles . Both lymphoid and epithelial cells in thethymus
stained normally for a monomorphic epitope on class I MHC antigens (data not
shown) . Both CD4+ andCD8+ cells were present at typical numbers in the thymic
cortex . A deficiency unique to the CD8` cells was apparent, however, in the medul-
la; no CD8 + cells were detected and almost all medullary thymocytes expressed the
CD4+ phenotype (Fig . 2).
The characteristics ofthis patient's immune system have precedents in those trans-
genicmice expressing transgenes for theTCR that recognizes themaleH-Y antigen
in the context of the class I MHC antigens (3). In the male HY transgenec mice,
FIGuRE 2 .
￿
Photomicrographs ofpatient thymus
and normal thymus. Comparison ofpatient's thy-
mus biopsy (a) to age-matched control thymus
(b) . Both show a normal architecture with cor-
tical and medullaryregions and formation ofHas-
sall's corpuscles (arrows) (x 110). Immunoperoxi-
dase staining forCD8 shows positive staining of
cortical thymocytes inpatient (c) andcontrol (d) .
Medullary thymocytes in the patient show only
rare positive staining (c), in contrast to frequent
positive cells in the control (d) ( x 280) . (e, f) Im-
munoperoxidasestaining forCD4 shows positive
staining of cortical thymocytes as well as most
medullary thymocytes in patient (e) and control
(j) (x 280).2180
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CD8+ cells are CD4+ CD8+ cortical thymocytes; CD4- CD8+ cells are depleted
from the thymic medulla and peripheral blood . This is attributed to high affinity
of theCD8+ cells with class IMHC antigen-bearing cells that leads to intrathymic
elimination of CD8+ cells by a process of negative selection (3) .
In search ofan explanation for the depletion ofCD8' cells, we examined the ex-
pression of CD8 mRNA in the patient's thymus and PBL (Fig. 3) . Northern blot
analysis ofRNA extracted from the PBL revealed the presence of normal levels of
mRNA coding for severalT cell surface proteins including CD3, CD4, and the a
and a polypeptides of the TCR, but the complete absence ofmRNA for both a
and a polypeptides ofCD8. Analysis ofRNA taken from frozen thymus tissue (taken
for histological purposes) detected aCD8 mRNA that was partially degraded (due
to the prolonged storage of the tissue) . To confirm that the RNA, rescued from the
thymic biopsy specimen, indeed contained CD8mRNA, we transcribed theRNA
into cDNA with reverse transcriptase and an oligonucleotide corresponding to the
CD8aV domain (11) . ThePCR wasthen used, with twooligonucleotides that frame
the CD8aV region, to amplify a 353-bp DNA fragment that was of the predicted
size and hybridized to aCD8a probe (Fig . 3 C) . We therefore conclude that cells
transcribing CD8 mRNA are present only in the thymus of this patient .
The surface molecules involved in intrathymic selection ofclassIMHC antigen-re-
stricted T cells include the CD8 a and R chains, the TCRa/R heterodimer, and
the classIMHC proteins . A mutation in or deletion of any one of these genes could
explain the phenotype observed in this immune deficient patient : a defect in the
binding site of theCD8 surface protein might impair its affinity toward the mono-
morphic site ofMHC classI molecules resulting in the absence of positive selection
of CD8+ cells in the thymus ; a deletion of a large portion of theTCRat or -(3 V
regions may result in elimination of those V region families able to interact with
FIGURE 3 .
￿
Northern blot analysis ofPBL and
thymocytes from the immune-deficient patient
and normal control. RNA was extracted from
PBL (A) and thymocytes (B) with guanidinium
isothyocyanate (8) . Northern blots were hybrid-
izedwith the indicated cDNA probes; CD80cDNA
was obtained from Dr. DanR . Littman (Univer-
sity ofCalifornia, San Francisco, CA) ; CD4 and
CD8a cDNAswere provided byDr. Richard Axel
(Columbia University, New York, NY); CD3
cDNAwas obtained from Dr . CoxTerhorst (Har-
vard Medical School, Boston, MA) .TCRa and
-# cDNAs wereobtained from Dr . TakMak (On-
tario Cancer Institute, Toronto, ON) . (C)A 353-
bp fragment was amplified as described(10) from
cDNAproduced by reverse transcription (MMLV
reverse transcriptase; BRL) ofRNA isolated from
a thymus biopsy. RNA was transcribed from a
primer specific to the CD8a V region (oligo
nucleotide CD8V3'-CTGGCAGGAAGACCGG-
CACGA); the cDNA was amplified using the
PCR with oligo nucleotide CD8V3' and asecond
primer oligo nucleotide CD8V5' (ACGCCGC-
CAGGCCGAGCCAGT). Identityofthe 353-bp
fragment was established through hybridization
to aCD8acDNA probe afterSouthernblotting.ROIFMAN ET AL.
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class I MHC moleculesofthis individual. The deletion ofmultiple members ofclass
I MHC moleculesin thispatientis notlikely sincenormal stainingofa monomorphic
epitope was observed in the patient's thymus (data not shown).
To determine ifa majordeletion ofTCR VS genes might explain the phenotype
observed in this patient, the expression ofall 20 VS gene families was determined
in her PBLs. RNA from the patient's peripheral blood was reverse transcribed with
an oligonucleotide corresponding to sequences common to human Col and Ca2.
The cDNA was amplified in 20PCRs using a CSprimer inall reactions and specific
to each reaction an oligonucleotide primer corresponding to a portion of the V0
region from 1 of20V/3families. The results clearly demonstrate thatall 20V16fami-
lies are expressed in this patient (data not shown). A major deletion of TCR V/3
genes can not explain the lack ofCD8' cells in the patient's peripheral blood.
A more likely explanation for the lack ofCD8+ cells in the thymic medulla and
periphery ofthis patient is an abnormality associated with the CD8 molecule. This
might involve a mutation intheCD8a or/3 coding sequences, amutation in regula-
tory sequences affecting CD8 expression in the periphery, or impaired signal trans-
duction after binding of ligand to the CD8 molecule.
The phenotype observedin this patienthasprovided aunique opportunity to ex-
amine the differential roles of CD4+ and CD8' T cell subsets in human immune
responses in vivo. The clinical and immunological observations both show that
CD4+ cells alone are sufficient for in vivo primary and secondary antibody re-
sponses. On the other hand, the lack ofCD8' cells results in failure to respond to
an allogeneic skin graft, illustrating the requirement for the CD8+ cells for class
I MHC antigen-restricted T cell responses in human.
The selective disappearance ofCD8' cells before their emergence in the thymic
medulla is compelling evidence for a process in the thymus targeting CD8' cells.
Whereas the majority of immature cortical thymocytes express the CD4+CD8+
phenotype, those that survive both positive and negative selection in the thymus
differentiate into either CD4+CD8- or CD4-CD8+ cells. In agreement with studies
on genetically manipulated andinbred mice(3-7), our studies ofan individual with
an error in thymic differentiation demonstrate that the process that regulates the
selection and amplification of CD4-CD8+ cells is clearly independent of and
separable from the processthat governs the differentiation into the CD4+CD8- cells.
The ability of the TCR on the CD4+CD8+ cells to interact with thymic peptides
presented byclassI orclassII MHC moleculeson undefined thymic cells may regu-
late these processes of differentiation. Aberrations in the process that targets the
CD8' cells lead to a depletion of these cells in the thymic medulla and peripheral
blood.
Summary
CD8 molecules expressed on the surface ofa subset ofT cells participate in the
selection ofclass I MHC antigen-restricted T cells in the thymus, and in MHC-
restricted immuneresponsesofmature class I MHC antigen-restricted Tcells. Here
we describe an immune-deficient patient with lack ofCD8' peripheral blood cells.
The patient presented with Pneumocystis carinii pneumonia and was unable to reject
an allogeneic skin graft, but hadnormal primary andsecondary antibody responses.
Examination ofthe patient's thymus revealed that the loss of CD8' cells occurred2182
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during intrathymic differentiation:, the patient's immature cortical thymocytes in-
cluded both CD4' and CD8* cells while the mature medullary cells expressed the
CD4butnot the Cp8 protein on theirsurface. Northernblotand polymerase chain
reaction analysesrevealedthepresence ofCD8aandS mRNA inthepatient'sthymus
but not in the peripheral blood. Both class I MHC antigen expression and the ex-
pressed TCR VO repertoire are normal in this patient. These data are consistent
with an impaired selection ofCD8+ cells in the patient's thymus and support the
role ofthe CD8 surface protein in thymic selection previously characterized in ge-
netically manipulated and inbred mice.
WethankDrs. DanLittman, RichardAxel,CoxTerhorst, andTakMakforsupplyingcDNA
probes.
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